Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EDIT | THRD | TVTX | ||
| Company | Editas Medicine | Third Harmonic Bio Inc | Travere Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.51 | 10.95 | 5.78 | ||
| High | 5.59 | 11.37 | 5.78 | ||
| Low | 5.28 | 10.73 | 5.34 | ||
| Last | 5.35 | 11.33 | 5.45 | ||
| Change | -0.11 | +0.28 | -0.29 | ||
| % Change | -2.01% | +2.53% | -5.05% | ||
| Volume | 1,908,300 | 156,400 | 2,777,700 | ||
| 20-Day Average Volume | 1,701,055 | 225,430 | 1,326,135 | ||
| Previous Close | 5.46 | 11.05 | 5.74 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.38 | 10.79 | 6.56 | ||
| 20-Day Raw Stochastic | 3.11% | 73.12% | 4.04% | ||
| 20-Day Relative Strength | 29.79% | 57.67% | 29.67% | ||
| Weighted Alpha | -60.33 | +129.97 | -67.99 | ||
| Today's Opinion | 88% Sell | 100% Buy | 100% Sell | ||
| Previous Opinion | 88% Sell | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 56% Sell | 40% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.63% since 04/17/24 | +0.44% since 04/17/24 | -9.02% since 04/17/24 | ||
| Low | 5.28 on 04/24/24 | 10.39 on 04/23/24 | 5.34 on 04/24/24 | ||
| High | 5.92 on 04/23/24 | 12.24 on 04/19/24 | 6.02 on 04/18/24 | ||
| 1-Month | |||||
| %Chg | -28.38% since 03/22/24 | +31.74% since 03/22/24 | -30.84% since 03/22/24 | ||
| Low | 5.28 on 04/24/24 | 8.36 on 04/01/24 | 5.34 on 04/24/24 | ||
| High | 7.59 on 03/25/24 | 12.42 on 04/11/24 | 8.11 on 03/25/24 | ||
| 3-Month | |||||
| %Chg | -33.46% since 01/24/24 | +22.35% since 01/24/24 | -39.85% since 01/24/24 | ||
| Low | 5.28 on 04/24/24 | 8.07 on 02/02/24 | 5.34 on 04/24/24 | ||
| High | 11.58 on 02/28/24 | 12.42 on 04/11/24 | 9.70 on 01/25/24 | ||
| 6-Month | |||||
| %Chg | -18.57% since 10/24/23 | +69.87% since 10/24/23 | -26.05% since 10/24/23 | ||
| Low | 5.28 on 04/24/24 | 5.76 on 11/08/23 | 5.25 on 11/10/23 | ||
| High | 11.69 on 12/06/23 | 12.42 on 04/11/24 | 10.27 on 01/10/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 449,003 | 450,365 | 436,866 | ||
| Shares Outstanding, K | 82,235 | 40,757 | 76,109 | ||
| Annual Sales | 78,120,000 | 0 | 145,240,000 | ||
| Annual Net Income | -153,220,000 | -30,820,000 | -111,400,000 | ||
| Last Quarter Sales | 60,050,000 | 0 | 37,100,000 | ||
| Last Quarter Net Income | -18,870,000 | -6,840,000 | 150,740,000 | ||
| 60-Month Beta | 2.01 | 3.53 | 0.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 02/28/24 | 0.17 on 03/26/24 | -1.16 on 02/15/24 | ||
| Latest Earnings Date | 05/03/24 | 05/09/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 08/06/14 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||